J 2022

Cytocompatibility and Bioactive Ion Release Profiles of Phosphoserine Bone Adhesive: Bridge from In Vitro to In Vivo

VRCHOVECKÁ, Kateřina, Monika PÁVKOVÁ GOLDBERGOVÁ, H. ENGQVIST and M. PUJARI-PALMER

Basic information

Original name

Cytocompatibility and Bioactive Ion Release Profiles of Phosphoserine Bone Adhesive: Bridge from In Vitro to In Vivo

Authors

VRCHOVECKÁ, Kateřina (203 Czech Republic, belonging to the institution), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Czech Republic, belonging to the institution), H. ENGQVIST (guarantor) and M. PUJARI-PALMER

Edition

Biomedicines, Basel, MDPI, 2022, 2227-9059

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30105 Physiology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.700

RIV identification code

RIV/00216224:14110/22:00125642

Organization unit

Faculty of Medicine

UT WoS

000785046500001

Keywords in English

phosphoserine; bone tissue adhesive; calcium phosphate cement; odontoblast; osteoblast; cytotoxicity; ion release; in vitro

Tags

Tags

International impact, Reviewed
Změněno: 20/2/2023 11:11, Mgr. Tereza Miškechová

Abstract

V originále

One major challenge when developing new biomaterials is translating in vitro testing to in vivo models. We have recently shown that a single formulation of a bone tissue adhesive, phosphoserine modified cement (PMC), is safe and resorbable in vivo. Herein, we screened many new adhesive formulations, for cytocompatibility and bioactive ion release, with three cell lines: MDPC23 odontoblasts, MC3T3 preosteoblasts, and L929 fibroblasts. Most formulations were cytocompatible by indirect contact testing (ISO 10993-12). Formulations with larger amounts of phosphoserine (>50%) had delayed setting times, greater ion release, and cytotoxicity in vitro. The trends in ion release from the adhesive that were cured for 24 h (standard for in vitro) were similar to release from the adhesives cured only for 5–10 min (standard for in vivo), suggesting that we may be able to predict the material behavior in vivo, using in vitro methods. Adhesives containing calcium phosphate and silicate were both cytocompatible for seven days in direct contact with cell monolayers, and ion release increased the alkaline phosphatase (ALP) activity in odontoblasts, but not pre-osteoblasts. This is the first study evaluating how PMC formulation affects osteogenic cell differentiation (ALP), cytocompatibility, and ion release, using in situ curing conditions similar to conditions in vivo.

Links

MUNI/A/1391/2021, interní kód MU
Name: Molekulární, buněčná, tkáňová a systémová patofyziologie vybraných komplexních nemocí (Acronym: KOMPLEX_PF)
Investor: Masaryk University
NU20-08-00149, research and development project
Name: Multicentrické hodnocení hypersenzitivní reakce u pacientů indikovaných k totální náhradě kloubu včetně hodnocení důvodů reimplanace
Investor: Ministry of Health of the CR, Subprogram 1 - standard